209 related articles for article (PubMed ID: 19319817)
1. [The TRPV1 channel as a target for the treatment of pain].
Salazar H; Jara-Oseguera A; Rosenbaum T
Rev Neurol; 2009 Apr 1-15; 48(7):357-64. PubMed ID: 19319817
[TBL] [Abstract][Full Text] [Related]
2. Ion channels in analgesia research.
Rosenbaum T; Simon SA; Islas LD
Methods Mol Biol; 2010; 617():223-36. PubMed ID: 20336426
[TBL] [Abstract][Full Text] [Related]
3. Capsaicin receptor: TRPV1 a promiscuous TRP channel.
Pingle SC; Matta JA; Ahern GP
Handb Exp Pharmacol; 2007; (179):155-71. PubMed ID: 17217056
[TBL] [Abstract][Full Text] [Related]
4. Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival?
Knotkova H; Pappagallo M; Szallasi A
Clin J Pain; 2008 Feb; 24(2):142-54. PubMed ID: 18209521
[TBL] [Abstract][Full Text] [Related]
5. TRPing the switch on pain: an introduction to the chemistry and biology of capsaicin and TRPV1.
Conway SJ
Chem Soc Rev; 2008 Aug; 37(8):1530-45. PubMed ID: 18648679
[TBL] [Abstract][Full Text] [Related]
6. Involvement of capsaicin-sensitive afferents and the Transient Receptor Potential Vanilloid 1 Receptor in xylene-induced nocifensive behaviour and inflammation in the mouse.
Sándor K; Helyes Z; Elekes K; Szolcsányi J
Neurosci Lett; 2009 Feb; 451(3):204-7. PubMed ID: 19159661
[TBL] [Abstract][Full Text] [Related]
7. Fire in the hole: pore dilation of the capsaicin receptor TRPV1.
Bautista D; Julius D
Nat Neurosci; 2008 May; 11(5):528-9. PubMed ID: 18437189
[No Abstract] [Full Text] [Related]
8. ThermoTRP channels as modular proteins with allosteric gating.
Latorre R; Brauchi S; Orta G; Zaelzer C; Vargas G
Cell Calcium; 2007; 42(4-5):427-38. PubMed ID: 17499848
[TBL] [Abstract][Full Text] [Related]
9. TRPV1: a therapeutic target for novel analgesic drugs?
Szallasi A; Cruz F; Geppetti P
Trends Mol Med; 2006 Nov; 12(11):545-54. PubMed ID: 16996800
[TBL] [Abstract][Full Text] [Related]
10. Contribution of natural products to the discovery of the transient receptor potential (TRP) channels family and their functions.
Calixto JB; Kassuya CA; André E; Ferreira J
Pharmacol Ther; 2005 May; 106(2):179-208. PubMed ID: 15866319
[TBL] [Abstract][Full Text] [Related]
11. Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia.
Honore P; Chandran P; Hernandez G; Gauvin DM; Mikusa JP; Zhong C; Joshi SK; Ghilardi JR; Sevcik MA; Fryer RM; Segreti JA; Banfor PN; Marsh K; Neelands T; Bayburt E; Daanen JF; Gomtsyan A; Lee CH; Kort ME; Reilly RM; Surowy CS; Kym PR; Mantyh PW; Sullivan JP; Jarvis MF; Faltynek CR
Pain; 2009 Mar; 142(1-2):27-35. PubMed ID: 19135797
[TBL] [Abstract][Full Text] [Related]
12. Role of rat sensory neuron-specific receptor (rSNSR1) in inflammatory pain: contribution of TRPV1 to SNSR signaling in the pain pathway.
Ndong C; Pradhan A; Puma C; Morello JP; Hoffert C; Groblewski T; O'Donnell D; Laird JM
Pain; 2009 May; 143(1-2):130-7. PubMed ID: 19307060
[TBL] [Abstract][Full Text] [Related]
13. TRPV1 antagonists: the challenges for therapeutic targeting.
Khairatkar-Joshi N; Szallasi A
Trends Mol Med; 2009 Jan; 15(1):14-22. PubMed ID: 19097938
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks.
Wong GY; Gavva NR
Brain Res Rev; 2009 Apr; 60(1):267-77. PubMed ID: 19150372
[TBL] [Abstract][Full Text] [Related]
15. Hot receptors in the brain.
Steenland HW; Ko SW; Wu LJ; Zhuo M
Mol Pain; 2006 Nov; 2():34. PubMed ID: 17092351
[TBL] [Abstract][Full Text] [Related]
16. Feedback mechanisms in the regulation of intracellular calcium ([Ca2+]i) in the peripheral nociceptive system: role of TRPV-1 and pain related receptors.
Hagenacker T; Ledwig D; Büsselberg D
Cell Calcium; 2008 Mar; 43(3):215-27. PubMed ID: 17673288
[TBL] [Abstract][Full Text] [Related]
17. Possible role for TRPV1 in neomycin-induced inhibition of visceral hypersensitivity in rat.
van den Wijngaard RM; Welting O; Bulmer DC; Wouters MM; Lee K; de Jonge WJ; Boeckxstaens GE
Neurogastroenterol Motil; 2009 Aug; 21(8):863-e60. PubMed ID: 19298229
[TBL] [Abstract][Full Text] [Related]
18. Painful toxins acting at TRPV1.
Cromer BA; McIntyre P
Toxicon; 2008 Feb; 51(2):163-73. PubMed ID: 18061640
[TBL] [Abstract][Full Text] [Related]
19. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept.
Szallasi A; Cortright DN; Blum CA; Eid SR
Nat Rev Drug Discov; 2007 May; 6(5):357-72. PubMed ID: 17464295
[TBL] [Abstract][Full Text] [Related]
20. The TRPV1 ion channel: implications for respiratory sensation and dyspnea.
Fisher JT
Respir Physiol Neurobiol; 2009 May; 167(1):45-52. PubMed ID: 19450765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
